FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2649206924> ?p ?o ?g. }

• W2649206924 abstract "The effect of enzalutamide on health-related quality of life (HRQoL) in the PREVAIL trial in chemotherapy-naïve men with metastatic castration-resistant prostate cancer was analyzed using the generic EQ-5D instrument. Patients received oral enzalutamide 160 mg/day (n = 872) or placebo (n = 845). EQ-5D index and EQ-5D visual analogue scale (EQ-5D VAS) scores were evaluated at baseline, week 13, and every 12 weeks until week 61 due to sample size reduction thereafter. Changes on individual dimensions were assessed, and Paretian Classification of Health Change (PCHC) and time-to-event analyses were conducted. With enzalutamide, EQ-5D index and EQ-5D VAS scores declined more slowly versus placebo and time to diverge from full health was prolonged. Average decline in EQ-5D index (−0.042 vs. –0.070; P < .0001) and EQ-5D VAS (−1.3 vs. –4.4; P < .0001) was significantly smaller with enzalutamide. There were significant (P < .05) between-group differences favoring enzalutamide in Pain/Discomfort to week 37, Anxiety/Depression at week 13, and Usual Activities at week 25, but no significant differences for Mobility and Self-care. The PCHC analysis showed more enzalutamide patients reporting improvement than placebo patients at weeks 13, 25, and 49 (all P < .05) and week 37 (P = .0512). Enzalutamide was superior (P ≤ .0003) to placebo for time to diverge from full health and time to first deterioration on Pain/Discomfort and Anxiety/Depression dimensions. This in-depth post hoc analysis showed that enzalutamide delayed HRQoL deterioration and had beneficial effects on several HRQoL domains, including Pain/Discomfort and the proportion of patients in full health, compared with placebo, and may help to support future analyses of this type. NCT01212991" @default.
• W2649206924 created "2017-06-30" @default.
• W2649206924 creator A5006750775 @default.
• W2649206924 creator A5020692060 @default.
• W2649206924 creator A5027991868 @default.
• W2649206924 creator A5028417408 @default.
• W2649206924 creator A5031897059 @default.
• W2649206924 creator A5048477205 @default.
• W2649206924 creator A5049802422 @default.
• W2649206924 creator A5079466405 @default.
• W2649206924 creator A5079806490 @default.
• W2649206924 creator A5081484302 @default.
• W2649206924 creator A5086126811 @default.
• W2649206924 creator A5089739735 @default.
• W2649206924 date "2017-06-23" @default.
• W2649206924 modified "2023-10-10" @default.
• W2649206924 title "Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial" @default.
• W2649206924 cites W1796686219 @default.
• W2649206924 cites W1970832311 @default.
• W2649206924 cites W1994222210 @default.
• W2649206924 cites W1997253444 @default.
• W2649206924 cites W2004909463 @default.
• W2649206924 cites W2013851543 @default.
• W2649206924 cites W2026764315 @default.
• W2649206924 cites W2037951148 @default.
• W2649206924 cites W2038019114 @default.
• W2649206924 cites W2045336297 @default.
• W2649206924 cites W2065526121 @default.
• W2649206924 cites W2098428600 @default.
• W2649206924 cites W2099018307 @default.
• W2649206924 cites W2110841574 @default.
• W2649206924 cites W2118416083 @default.
• W2649206924 cites W2119504728 @default.
• W2649206924 cites W2119529210 @default.
• W2649206924 cites W2122089361 @default.
• W2649206924 cites W2125942853 @default.
• W2649206924 cites W2127307826 @default.
• W2649206924 cites W2131156409 @default.
• W2649206924 cites W2131952914 @default.
• W2649206924 cites W2140525590 @default.
• W2649206924 cites W2142200772 @default.
• W2649206924 cites W2146360937 @default.
• W2649206924 cites W2148643283 @default.
• W2649206924 cites W2153148011 @default.
• W2649206924 cites W2153836018 @default.
• W2649206924 cites W2155374149 @default.
• W2649206924 cites W2161824335 @default.
• W2649206924 cites W2166918329 @default.
• W2649206924 cites W2167331614 @default.
• W2649206924 cites W2167571044 @default.
• W2649206924 cites W2473786944 @default.
• W2649206924 doi "https://doi.org/10.1186/s12955-017-0704-y" @default.
• W2649206924 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5481866" @default.
• W2649206924 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28645287" @default.
• W2649206924 hasPublicationYear "2017" @default.
• W2649206924 type Work @default.
• W2649206924 sameAs 2649206924 @default.
• W2649206924 citedByCount "24" @default.
• W2649206924 countsByYear W26492069242017 @default.
• W2649206924 countsByYear W26492069242018 @default.
• W2649206924 countsByYear W26492069242019 @default.
• W2649206924 countsByYear W26492069242020 @default.
• W2649206924 countsByYear W26492069242021 @default.
• W2649206924 countsByYear W26492069242022 @default.
• W2649206924 countsByYear W26492069242023 @default.
• W2649206924 crossrefType "journal-article" @default.
• W2649206924 hasAuthorship W2649206924A5006750775 @default.
• W2649206924 hasAuthorship W2649206924A5020692060 @default.
• W2649206924 hasAuthorship W2649206924A5027991868 @default.
• W2649206924 hasAuthorship W2649206924A5028417408 @default.
• W2649206924 hasAuthorship W2649206924A5031897059 @default.
• W2649206924 hasAuthorship W2649206924A5048477205 @default.
• W2649206924 hasAuthorship W2649206924A5049802422 @default.
• W2649206924 hasAuthorship W2649206924A5079466405 @default.
• W2649206924 hasAuthorship W2649206924A5079806490 @default.
• W2649206924 hasAuthorship W2649206924A5081484302 @default.
• W2649206924 hasAuthorship W2649206924A5086126811 @default.
• W2649206924 hasAuthorship W2649206924A5089739735 @default.
• W2649206924 hasBestOaLocation W26492069241 @default.
• W2649206924 hasConcept C118552586 @default.
• W2649206924 hasConcept C121608353 @default.
• W2649206924 hasConcept C126322002 @default.
• W2649206924 hasConcept C139719470 @default.
• W2649206924 hasConcept C14184104 @default.
• W2649206924 hasConcept C142724271 @default.
• W2649206924 hasConcept C159110408 @default.
• W2649206924 hasConcept C162324750 @default.
• W2649206924 hasConcept C168563851 @default.
• W2649206924 hasConcept C1862650 @default.
• W2649206924 hasConcept C204787440 @default.
• W2649206924 hasConcept C27081682 @default.
• W2649206924 hasConcept C2776551883 @default.
• W2649206924 hasConcept C2776867660 @default.
• W2649206924 hasConcept C2778739829 @default.
• W2649206924 hasConcept C2779951463 @default.
• W2649206924 hasConcept C2780192828 @default.
• W2649206924 hasConcept C558461103 @default.
• W2649206924 hasConcept C61367390 @default.
• W2649206924 hasConcept C67761136 @default.
• W2649206924 hasConcept C71924100 @default.

• next